About Hospital Universitario 12 de Octubre; Servicio de Neurologia
The Hospital Universitario 12 de Octubre is a public general hospital in the neighborhood of Orcasur, in Madrid, Spain. It is part of the hospital network of the Servicio Madrileño de Salud.
There are 1,256 beds in Hospital Universitario 12 de Octubre; Servicio de Neurologia.
Clinical Trials at Hospital Universitario 12 de Octubre; Servicio de Neurologia
During the past decade, Hospital Universitario 12 de Octubre; Servicio de Neurologia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario 12 de Octubre; Servicio de Neurologia"
#1 collaborator was "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital Universitario 12 de Octubre; Servicio de Neurologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario 12 de Octubre; Servicio de Neurologia" are
"Alzheimer Disease" (4 trials), "Alzheimer's Disease" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Multiple Sclerosis" (1 trials) and "Parkinsons Disease" (1 trials). Many other conditions were trialed in "Hospital Universitario 12 de Octubre; Servicio de Neurologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario 12 de Octubre; Servicio de Neurologia
Most popular intervention types in "Hospital Universitario 12 de Octubre; Servicio de Neurologia" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (6 trials), "Placebo" (5 trials), "Crenezumab" (2 trials), "Ocrelizumab" (2 trials) and "Prasinezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario 12 de Octubre; Servicio de Neurologia
The vast majority of trials in "Hospital Universitario 12 de Octubre; Servicio de Neurologia" are
12 trials for "All" genders.
Clinical Trials Status at Hospital Universitario 12 de Octubre; Servicio de Neurologia
Currently, there are NaN active trials in "Hospital Universitario 12 de Octubre; Servicio de Neurologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitario 12 de Octubre; Servicio de Neurologia,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario 12 de Octubre; Servicio de Neurologia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".